Cite

HARVARD Citation

    Volokhina, E. et al. (2017). Eculizumab Dosing Regimen in Atypical HUS: Possibilities for Individualized Treatment. Clinical pharmacology & therapeutics. 102 (4), pp. 671-678. [Online]. 
  
Back to record